Long COVID Symptoms and Management: A Doctor-Reviewed Guide

11 min read Updated 31 May 2026 Medically reviewed

Disclosure: 247healthcare.blog publishes general health education reviewed by qualified doctors. Some articles contain affiliate links. This post does not. Our editorial process and medical review are independent of any commercial relationship. Full disclosure policy.

Key takeaways

Long COVID is defined by NICE NG188 as symptoms continuing more than 12 weeks after COVID-19 not explained by alternative diagnosis. The WHO post COVID-19 condition definition requires symptoms lasting at least 2 months and occurring at least 3 months from infection.
Six symptom clusters are recognised: fatigue and post-exertional malaise, respiratory, cardiovascular and autonomic, neurological and cognitive, sensory (smell and taste), and mental health. Most patients have symptoms across multiple clusters.
Post-exertional malaise (PEM), the worsening of symptoms 12 to 48 hours after activity, is a hallmark feature. When PEM is present, graded exercise therapy is not appropriate per NICE NG206 and NG188; pacing is the management approach.
POTS (postural orthostatic tachycardia syndrome) may affect up to a third of long COVID patients. Recognising it changes management substantially. Diagnosis is via active stand test or tilt table test.
Most current treatments are symptom-focused. Several proposed disease-modifying therapies are in clinical trials but not yet standard care. Be cautious of unproven, expensive treatments marketed as long COVID cures.

Medically reviewed by Dr. Ravi Sishir Reddy (MBBS, MD General Medicine), Internal Medicine and Critical Care, with 15 years of clinical experience including long COVID and post-viral syndrome management since 2020. NMC-registered, verifiable on the Indian Medical Register.

Last updated: 31 May 2026 | Last medically reviewed: 31 May 2026

The acute COVID-19 illness settled weeks or months ago. The PCR or RAT was negative. But the symptoms did not stop. Fatigue that does not respond to rest. Breathlessness on walking up the stairs. Brain fog at work. Palpitations on standing. Sleep that does not refresh. This is long COVID, recognised by NICE, WHO, CDC, and India's ICMR as a real and distinct condition with its own evolving management framework. This guide walks through the definitions, the six symptom clusters, the central role of pacing, symptom-by-symptom management, and the honest answer on what treatments actually have evidence.

What long COVID is, the definitions

Long COVID is a working name for a clinical condition that has more formal labels in different health systems. The two most-cited definitions:

NICE NG188 (UK). The National Institute for Health and Care Excellence defines two phases. Ongoing symptomatic COVID-19: signs and symptoms from 4 to 12 weeks after the start of acute COVID-19. Post-COVID-19 syndrome: signs and symptoms that develop during or after COVID-19, continue for more than 12 weeks, and are not explained by an alternative diagnosis. Symptoms may change over time, affect any system in the body, and can fluctuate and relapse.

WHO post COVID-19 condition. The World Health Organization defines post COVID-19 condition as a condition that occurs in individuals with a history of probable or confirmed SARS-CoV-2 infection, usually 3 months from the onset of COVID-19, with symptoms lasting for at least 2 months that cannot be explained by an alternative diagnosis. Common symptoms include fatigue, shortness of breath, cognitive dysfunction, and others that generally have an impact on everyday functioning.

Both definitions require persistent or new symptoms after the acute illness, attribution to the SARS-CoV-2 infection, and exclusion of alternative diagnoses. ICD-10 code U09.9 (post COVID-19 condition, unspecified) is the standard administrative code in many health systems including India.

How common it is

10-15%

commonly cited population estimate of long COVID at 12 weeks after SARS-CoV-2 infection in unvaccinated adults. Rates appear lower with more recent variants and in vaccinated individuals. Estimates vary substantially across studies depending on the definition used, the population studied, and the timing in the pandemic. The WHO post COVID-19 condition resource and the CDC long COVID page both reflect this evolving evidence base.

Population-level estimates from large studies have ranged from 5 percent to 30 percent of infected adults experiencing some persistent symptoms at 12 weeks. The variation is real and reflects three factors. First, the definition matters: stricter criteria (multiple symptoms substantially affecting function) give lower numbers than broader criteria (any persistent symptom). Second, vaccination reduces long COVID risk significantly. Third, more recent SARS-CoV-2 variants appear associated with lower long COVID rates than the early pandemic variants.

Even with the lower estimates, the absolute numbers globally are large. Long COVID has produced the largest single cohort of post-viral syndrome patients in modern medical history.

Who gets long COVID

Several patterns have emerged from observational studies.

Sex: women are affected more often than men, by roughly 1.5 to 2 times.
Age: most common in middle-aged adults (35 to 60 years), though all ages can be affected.
Severity of acute COVID-19: while severe initial illness increases risk, a substantial fraction of long COVID patients had mild or even asymptomatic acute COVID-19.
Vaccination status: being vaccinated before infection reduces long COVID risk.
Prior medical conditions: obesity, type 2 diabetes, asthma, and prior mental health conditions are associated with higher risk.
Multiple infections: reinfection appears to increase the risk of long COVID per some studies.

None of these factors is necessary or sufficient. Long COVID has been documented in young, otherwise healthy adults with mild acute COVID-19 and full vaccination. The risk-factor model is statistical rather than deterministic.

The six symptom clusters

Long COVID symptoms span multiple body systems. Grouping them into clusters helps both diagnosis and management. Most patients have symptoms across at least two clusters; many across four or more.

1. Fatigue and post-exertional malaise

The most consistently reported cluster. Profound tiredness beyond normal post-illness recovery, often with post-exertional malaise (PEM) where symptoms worsen 12 to 48 hours after physical or mental activity. Unrefreshing sleep is common.

2. Respiratory

Breathlessness on activity that did not previously occur, persistent cough, chest tightness. Sometimes related to ongoing lung changes; often related to deconditioning, breathing pattern dysfunction, or anxiety overlay.

3. Cardiovascular and autonomic

Palpitations, postural light-headedness, rapid heart rate on standing (suggesting POTS), chest pain, exercise intolerance disproportionate to fitness level. Autonomic dysfunction is increasingly recognised as central.

4. Neurological and cognitive

Brain fog (difficulty concentrating, word-finding problems, slowed thinking), headache, peripheral nerve tingling, sleep disturbance, dizziness. The cognitive symptoms are often the most disabling for working-age adults.

5. Sensory (smell and taste)

Persistent loss of smell (anosmia) or altered smell (parosmia, where familiar smells now smell unpleasant or different). Loss of taste often resolves earlier than smell. Around 5 percent of long COVID patients have persistent smell or taste alterations at 6 to 12 months.

6. Mental health

Anxiety, depression, post-traumatic stress symptoms (particularly in patients who had severe acute illness or ICU stay). Sleep disturbance and persistent fatigue compound these symptoms in both directions.

Post-exertional malaise in long COVID

Post-exertional malaise (PEM) is a worsening of symptoms following physical or mental activity, typically appearing 12 to 48 hours later and lasting hours to days. A patient may feel relatively well on Wednesday, do a normal day of work, and crash on Thursday evening with worse fatigue, brain fog, and breathlessness than they had during the acute COVID-19 illness.

PEM is reported by a substantial fraction of long COVID patients. The clinical importance is that it changes how exercise and reactivation should be approached. The historical graded exercise therapy (GET) model assumes progressive increase will improve fitness; in the presence of PEM, GET often causes harm.

The NICE NG206 ME/CFS guideline (2021) formally moved away from GET in favour of pacing. NICE NG188 applies the same principle to long COVID with PEM. The post-viral fatigue article in this series covers PEM and pacing in detail.

Pacing as the cornerstone

Pacing protocol

1. Identify your current sustainable level. Track for a week. What activity level allows you to wake the next morning at the same baseline, not worse?

2. Plan activity within the envelope. Break the day into blocks. Build in 10 to 15 minute rests between blocks, even on good days.

3. Stop before exhaustion, not at exhaustion. Aim for 60 to 70 percent of what feels possible, not 100 percent. The energy you do not spend today is what allows tomorrow to be normal.

4. Expand gradually. Increase activity by 10 to 20 percent only after the current level has felt sustainable for at least 7 days. If a step up causes a crash, return to the previous level for 2 weeks.

5. Track patterns. A daily diary reveals what triggers PEM more clearly than memory alone. Mental effort (work meetings, screen time, emotional stress) is often as draining as physical activity.

Pacing does not cure long COVID. It does prevent the boom-and-bust cycle that prolongs recovery and risks long-term worsening. For patients without PEM, pacing is still useful but reactivation can be more flexible.

Managing fatigue specifically

The most consistently reported and often most disabling symptom. Management combines pacing with several supporting interventions.

Sleep optimisation. 8 to 9 hours nightly with consistent sleep and wake times. Address sleep apnoea if symptoms suggest it.
Nutrition. Protein 1 to 1.2 g/kg/day, balanced micronutrients, treat documented deficiencies (vitamin D, B12, iron).
Caffeine moderation. Some patients find caffeine helpful in the short term but it can worsen autonomic symptoms and sleep quality. Reasonable trial reduction may be useful.
Stimulant medications. Modafinil and similar drugs are sometimes used in specialist clinics for selected patients but should not be initiated without clinical assessment.
Address mood. Untreated depression and anxiety amplify fatigue; treating them improves the overall picture.
Treat any comorbid contributors. Anaemia, hypothyroidism, uncontrolled diabetes, sleep apnoea, and untreated mental health conditions all amplify long COVID fatigue.

Breathlessness management

Persistent breathlessness after COVID-19 has several possible underlying contributors. Distinguishing them changes management.

Rule out ongoing lung pathology

Chest X-ray and oxygen saturation at rest and on walking are basic. If abnormal, further workup (high-resolution CT, lung function tests, sometimes pulmonary embolism evaluation) may be needed. Most long COVID breathlessness is not due to active lung pathology but ruling it out is important.

Address breathing pattern dysfunction

Many long COVID patients develop subtly altered breathing patterns (rapid shallow breathing, frequent sighing, mouth breathing at rest). Breathing retraining with a respiratory physiotherapist can substantially reduce symptoms. NHS UK long COVID resources include breathing exercise videos.

Treat deconditioning carefully

If there is no PEM and no autonomic symptoms, gradual aerobic reconditioning helps. Start with low-intensity walks and increase by 10 to 20 percent weekly. If PEM is present, this approach is contraindicated; stick to pacing within the envelope.

Consider autonomic contribution

Breathlessness on standing or with postural change may reflect POTS rather than primary lung pathology. The next section covers POTS recognition and management.

Brain fog and cognitive symptoms

Cognitive symptoms are often the most disabling for working-age adults with long COVID. They include difficulty concentrating, slowed processing, word-finding problems, short-term memory difficulty, and reduced executive function.

Practical management strategies:

Cognitive pacing. The same principle as physical pacing applies to mental effort. Break cognitively demanding work into shorter blocks with rests between. Avoid scheduling multiple cognitive challenges in one day.
Reduce cognitive load with structure. Lists, calendars, reminders, and structured routines compensate for reduced working memory.
Address sleep. Cognitive symptoms reliably worsen with poor sleep. 8 to 9 hours of quality sleep helps more than any cognitive supplement.
Treat mood symptoms. Untreated depression and anxiety produce cognitive symptoms in their own right. Treating them improves the cognitive picture.
Cognitive rehabilitation. Some long COVID clinics offer structured cognitive rehabilitation programmes; evidence is emerging.
Workplace accommodation. Frank conversation with employer about temporary reduced cognitive load, written confirmation of decisions, recorded meetings, and reduced multitasking expectations.

Palpitations and POTS

Postural orthostatic tachycardia syndrome (POTS) is a form of autonomic dysfunction characterised by an excessive heart rate increase on standing without significant blood pressure drop. POTS is increasingly recognised as a long COVID manifestation, with some studies suggesting it affects up to a third of long COVID patients with autonomic symptoms.

How to recognise possible POTS.

Heart rate increase of more than 30 beats per minute (or to more than 120) within 10 minutes of standing
Persistent light-headedness, palpitations, or fatigue on standing
Brain fog and reduced exercise tolerance, particularly upright
Symptoms improve with sitting or lying down

Diagnostic confirmation. Active stand test (10 minutes of standing with heart rate measurement) or tilt table test in a cardiology or autonomic specialist setting.

Management. Increased salt intake (3 to 10 g daily, depending on individual response), increased fluid intake (2.5 to 3 litres daily), compression garments (abdominal binders or thigh-high compression stockings), gradual reconditioning starting with recumbent exercise (recumbent cycling, swimming), and sometimes medications including ivabradine or low-dose beta blockers, fludrocortisone, or midodrine. Specialist input is usually appropriate.

Loss of smell and taste

Persistent smell loss (anosmia) or altered smell (parosmia, where familiar smells now smell wrong or unpleasant) is reported by around 5 percent of long COVID patients at 6 to 12 months. The mechanism is thought to involve damage to the olfactory sensory neurons and the supporting olfactory epithelium.

Management:

Olfactory training. Structured sniffing of distinct smells (rose, eucalyptus, lemon, clove are commonly used) twice daily for 12 to 24 weeks. Evidence supports modest benefit for recovery rates.
Time. Most patients improve gradually over 12 to 24 months even without specific treatment. Parosmia often improves before anosmia resolves completely.
Nutrition support. Patients with altered smell often have reduced appetite and weight loss. Adequate calorie and protein intake matter even when food does not taste normal.
Safety adaptations. Smoke detectors in working order, careful checking of expiry dates on food, gas leak awareness. The loss of smell affects safety; explicit adaptation helps.

Persistent severe smell or taste loss at 12 months warrants ENT specialist review.

Mental health and long COVID

Mental health symptoms in long COVID have two sources. First, COVID-19 itself appears to have direct effects on the brain that increase the risk of depression and anxiety. Second, the experience of prolonged illness, disability, financial stress, and uncertainty about recovery produces psychological burden that affects mental health independently.

The clinical implication is that mental health symptoms should be assessed and treated alongside physical symptoms, not as an afterthought and not as evidence that the physical symptoms are imagined. Both layers are real and both deserve treatment.

Evidence-supported approaches include cognitive behavioural therapy adapted for chronic illness, antidepressant medication where indicated, structured social support, and peer support groups (long COVID patient communities exist online and in-person across most major cities globally and increasingly in India).

The treatment landscape honestly

The honest position on long COVID treatment as of 2026 is that most current approaches are symptom-focused rather than disease-modifying. Several proposed disease-modifying therapies are in clinical trials but have not yet been established as standard care.

Treatment	Status	Evidence summary
Pacing and symptom management	Standard care	NICE NG188 and CDC guidance both endorse. Strong consensus.
Treatment of identified comorbidities (deficiencies, mood, sleep apnoea, diabetes)	Standard care	Improves long COVID picture by removing other contributors. Strong rationale.
Olfactory training for smell loss	Standard care for anosmia	Modest benefit on recovery rates per multiple studies.
POTS-specific therapies (salt, fluids, compression, ivabradine, beta blockers)	Standard care when POTS confirmed	Adapted from pre-existing POTS literature; reasonable evidence base.
Low-dose naltrexone (LDN)	Investigational	Some observational reports of benefit; randomised controlled trials underway. Not yet standard care.
Extended antiviral courses (Paxlovid, others)	Investigational	Trials testing whether persistent viral reservoirs respond to extended antiviral. Results pending or early.
Monoclonal antibodies for persistent symptoms	Investigational	Limited trial data; not standard care.
Immunomodulators (IL-6 blockers, others)	Investigational	Specific subgroups under study; not standard care.
Hyperbaric oxygen therapy	Limited evidence	Some small trial benefit reported; methodology contested; not standard care.
Stellate ganglion blocks	Limited evidence	Some case reports and small series; not standard care.
Branded "long COVID recovery" supplements and protocols	Not recommended	Heavy marketing, weak to no evidence. Often expensive. Be cautious.

The general principle: be open to therapies with emerging evidence in trial settings, but be cautious of expensive treatments marketed as cures outside that evidence base. The legitimate care pathway is unglamorous but real.

When to seek specialist care

A general physician can usually initiate long COVID assessment and basic management. Specialist input is helpful in several situations.

Dedicated long COVID clinic

Multi-specialty services for assessment of multiple symptom clusters, available in NHS UK, US academic centres, EU healthcare systems, and increasingly in major Indian hospitals. Best for patients with multiple system involvement.

Cardiology

For palpitations, chest pain, exercise intolerance, or suspected POTS. Evaluation may include ECG, echocardiogram, Holter monitor, tilt table test.

Pulmonology / respiratory medicine

For persistent breathlessness, abnormal chest imaging, or breathlessness that does not respond to general measures. Lung function testing and HRCT may be appropriate.

Neurology

For severe or progressive cognitive symptoms, focal neurological symptoms, persistent headaches, or peripheral nerve symptoms. May involve cognitive assessment and selected investigations.

ENT

For persistent smell or taste loss not responding to olfactory training at 6 to 12 months.

Psychiatry / clinical psychology

For significant depression, anxiety, post-traumatic stress, or sleep disturbance not responding to general measures.

Rehabilitation medicine

For graduated functional rehabilitation, particularly after severe acute COVID-19 or for patients with substantial disability.

Respiratory physiotherapy

For breathing pattern dysfunction, an underrecognised contributor to long COVID breathlessness. Structured breathing retraining can be substantial.

India context

Long COVID is recognised in India by ICMR and the Ministry of Health and Family Welfare. Several Indian centres have established dedicated post-COVID clinics, particularly at AIIMS Delhi, AIIMS Bhubaneswar, PGI Chandigarh, CMC Vellore, and many large private hospitals.

Specific patterns and challenges in the Indian context:

Underrecognition in primary care. Many Indian patients with long COVID symptoms are evaluated for other causes (tuberculosis, anaemia, vitamin deficiencies) before the long COVID diagnosis is considered. The differential is reasonable and these alternative explanations should be ruled out, but the time-to-diagnosis can be long.

Comorbidity overlap. India's high diabetes prevalence (around 11 percent of adults) creates substantial overlap between long COVID symptoms and uncontrolled diabetes symptoms. Iron deficiency anaemia is common, particularly in women. Vitamin D and B12 deficiency are widespread. All these should be checked and treated when long COVID is suspected; treating them frequently improves the overall picture.

Cost of investigation. A full long COVID workup (CBC, vitamin D, B12, ferritin, thyroid, chest X-ray, ECG, possibly Holter and echocardiogram) costs around 5,000 to 15,000 rupees in private settings, more if specialist consultations and advanced imaging are added. Public sector services are available but may have longer waits. ICMR-affiliated centres and government hospitals can provide care at lower cost.

Support resources. The Long COVID India network and various patient-led Indian communities have emerged since 2021. Online support groups in regional languages exist for several cities and states.

Red flags during long COVID

Long COVID symptoms can sometimes mask other diagnoses, and some long COVID complications need timely intervention.

New or worsening chest pain, particularly on exertion or with sweating.
Significant breathlessness at rest, or oxygen saturation falling below 94 percent on activity.
Sudden severe headache, vision changes, or one-sided weakness (possible stroke or cerebral venous thrombosis).
Calf swelling, redness, or pain (possible deep vein thrombosis).
Fainting or near-fainting episodes, particularly recurrent ones.
New severe abdominal pain, rectal bleeding, or unintended significant weight loss.
Mood symptoms with thoughts of self-harm or suicide; urgent mental health review needed.
New persistent fever after the original COVID-19 illness had settled, particularly with night sweats and weight loss (consider tuberculosis, lymphoma, other alternatives).
Progressive weakness, particularly focal weakness (one limb, one side).
Significant cognitive decline rather than fluctuating brain fog.

A note from Dr. Ravi Sishir Reddy

Long COVID is the largest single cohort of post-viral patients I have managed in my career. The clinical pattern that hurts me most to see is the patient who has been dismissed by multiple doctors before reaching mine, told their symptoms are anxiety or that they should just push through. That dismissal is wrong and it is exactly the failure mode that NICE NG188 and the global long COVID literature have tried to correct. My approach is straightforward: take the history seriously, do a focused workup to identify treatable contributors (deficiencies, diabetes, sleep apnoea, mood symptoms), recognise the specific patterns that change management (POTS, PEM, breathing pattern dysfunction), set realistic expectations about timeline, and refer onward when the patient needs multidisciplinary input. The recovery curve is variable but most patients do improve gradually. Pacing, sleep, nutrition, and treating what can be treated do more than any single therapy. The patients who do worst are the ones who try to push through PEM or who chase expensive unproven cures; the patients who do best are the ones who accept the constraint, treat what is treatable, and let time do its share.

Frequently asked questions

What is long COVID?

Long COVID is the persistence of symptoms following SARS-CoV-2 infection beyond the expected acute recovery period. NICE NG188 in the UK defines it as signs and symptoms that develop during or after COVID-19, continue for more than 12 weeks, and are not explained by an alternative diagnosis. The WHO post COVID-19 condition definition is symptoms lasting at least 2 months and occurring at least 3 months from the original infection. The condition can follow any severity of acute COVID-19, including initially mild illness.

How common is long COVID?

Estimates vary substantially by definition, population, and timing in the pandemic. Studies have reported rates from 5 percent to 30 percent of adults infected with SARS-CoV-2 experiencing some persistent symptoms at 12 weeks, with the most widely cited population estimates around 10 to 15 percent in unvaccinated individuals and lower in vaccinated populations. Rates appear lower with more recent SARS-CoV-2 variants and in vaccinated individuals. The condition affects more women than men and is most common in middle-aged adults.

What are the most common long COVID symptoms?

The most common symptoms are fatigue (often with post-exertional malaise), breathlessness, brain fog and cognitive impairment, palpitations and rapid heart rate (including postural changes), persistent cough, headache, loss or change in smell and taste, sleep disturbance, joint and muscle pain, and mental health symptoms (anxiety, depression). Most patients have several symptoms across multiple body systems rather than a single isolated complaint.

What is post-exertional malaise in long COVID?

Post-exertional malaise (PEM) is a worsening of symptoms (fatigue, brain fog, breathlessness, sleep disturbance, pain) that follows physical or mental activity, typically appearing 12 to 48 hours later and lasting hours to days. PEM is reported by a substantial fraction of long COVID patients and is a hallmark of ME/CFS. When PEM is present, graded exercise therapy is not appropriate per NICE NG206 and NG188; pacing is the recommended management approach.

What is pacing and how does it help long COVID?

Pacing is a structured energy management approach that helps prevent the boom-and-bust cycle (overdoing on a good day and crashing afterwards). The principle is to stay within your current energy envelope: plan activity, build in regular rest, stop before exhaustion, and expand gradually only when current levels are sustainable. NICE NG188 endorses pacing for long COVID, particularly when post-exertional malaise is present. The same approach is used for ME/CFS under NICE NG206. Pacing does not cure long COVID but reduces relapses and prevents long-term worsening.

What is POTS in long COVID?

POTS (postural orthostatic tachycardia syndrome) is a condition in which heart rate increases by more than 30 beats per minute within 10 minutes of standing, without a significant drop in blood pressure. It is associated with light-headedness, palpitations, fatigue, and brain fog on standing. POTS is a recognised long COVID manifestation, possibly affecting up to a third of patients in some series. Diagnosis involves an active stand test or tilt table test. Management includes increased salt and fluid intake, compression stockings, gradual reconditioning, and sometimes medications like ivabradine or beta blockers.

When should I see a doctor about long COVID?

See a doctor if you have persistent symptoms 12 weeks or more after acute COVID-19, particularly if symptoms substantially affect your work, family life, or daily functioning. Earlier review (4 to 8 weeks) is warranted for new or worsening symptoms like breathlessness at rest, chest pain, fainting episodes, severe brain fog, or significant mood symptoms. Dedicated long COVID assessment clinics exist in the UK, US, EU, and increasingly in India. A general physician can usually initiate the workup; complex cases benefit from multidisciplinary specialist input.

Are there evidence-based treatments for long COVID?

Most current treatments are symptom-focused rather than disease-modifying. Pacing, sleep optimisation, treating identified deficiencies (vitamin D, B12, iron), and addressing specific symptom clusters (POTS, mood, sleep, pain) all have evidence for benefit. Several proposed disease-modifying treatments (low-dose naltrexone, antiviral courses, monoclonal antibodies, immunomodulators) are under active investigation in clinical trials but have not yet been established as standard care. Be cautious about unproven and expensive treatments marketed as long COVID cures; the legitimate evidence-based options are unglamorous but real.

Medical disclaimer: This article is for general health education and does not replace consultation with a qualified healthcare professional. Long COVID is a complex evolving condition; specific management should be tailored to your individual symptoms, severity, and clinical context. New treatments may have emerged since this article was last reviewed. If your symptoms are severe, progressive, or accompanied by red flags described in this guide, please see a doctor.

About the author

247healthcare.blog editorial team writes general health and preventive medicine content reviewed by qualified doctors. Every article is fact-checked against current guidance from NICE, WHO, CDC, NHS, ICMR, BMJ, AAFP, and peer-reviewed medical literature before publication.

About the medical reviewer

Dr. Ravi Sishir Reddy (MBBS, MD General Medicine) is a Consultant Physician in Internal Medicine and Critical Care at Vivekananda Hospital, Begumpet, Hyderabad. He has 15 years of clinical experience including ICU care, infectious diseases, long COVID and post-viral syndrome management since 2020. NMC-registered, verifiable on the Indian Medical Register.